To the best of our knowledge, this is the first study on b-DMARDs drug survival in PsA patients and deficiency of vitamin D. Published studies on poor response to anti-TNF α treatment in the presence of insufficiency of vitamin D have only involved inflammatory bowel disease (IBD) patients. This evidence concerns the gene TNF and inflammatory bowel disease.